H1N1 develops rapidly in healthier young people leading to severe respiratory failure and death
US FDA is removing zanamivir from its approved packaging to be used for the purpose of nebulizing by patients who are unable to take oral medications or inhale Relenza
Serum plans to launch India's first indigenous H1N1 vaccine by early next year Serum Institute of India has started preclinical animal studies for its indigenous H1N1 swineflu vaccines in India. Serum Institute has begun studies to test the toxicity and safety of its experimental vaccine currently being developed before attempting to study ...
Berinert is the first and only therapy approved to treat acute abdominal and facial attacks of hereditary angioedema in US
Non-hormonal alternative drug Serada has been found effective in menopausal hot flashes in state-stage clinical studies, according to the developer of the drug Depomed.